Correction: The efficacy of angiogenesis inhibitors combined with chemotherapy in advanced breast cancer: a systematic review and meta-analysis - Report - MDSpire
Advertisement
Correction: The efficacy of angiogenesis inhibitors combined with chemotherapy in advanced breast cancer: a systematic review and meta-analysis
Clinical Report: Correction on Efficacy of Angiogenesis Inhibitors in Breast Cancer
Overview
Revise to include direct attribution to the source regarding the correction of author affiliations.
Background
Remove unsupported claims about the need for alternative strategies and the importance of understanding efficacy.
Data Highlights
No numerical or trial data is presented in the correction article.
Key Findings
The authors' affiliation was corrected to include the Department of Thyroid and Breast Surgery, Affiliated Hospital of North Sichuan Medical College.
The original article was published in Frontiers in Oncology.
The correction pertains to the authors Jiangzhuo Wu, Hanbing Li, Ling Wei, Xiao Yan, Jiang Fang, Lin Peng, and Xiaobo Zhao.
The systematic review and meta-analysis evaluates the effectiveness of angiogenesis inhibitors combined with chemotherapy in advanced breast cancer.
The original findings regarding the efficacy of the treatment combination remain unchanged.
Clinical Implications
The correction emphasizes the importance of accurate author affiliations in scientific publications. Clinicians should refer to the updated article for comprehensive insights into the efficacy of combining angiogenesis inhibitors with chemotherapy in advanced breast cancer.
Conclusion
The correction serves to clarify authorship and ensure proper attribution in the literature regarding the treatment of advanced breast cancer. Continued research in this area is essential for optimizing therapeutic strategies.
